From Lab to Line: CSIR Hands Four Home-Grown Technologies to Industry
UPSC-standard MCQs with explanations, trap analysis, and approach guide. Answer after the test — not before.
1
Easy
1
Medium
1
Hard
Practice this set
3 questions · full analysis after submission · no sign-up required
Article summary
The Council of Scientific and Industrial Research (CSIR) transferred four indigenously developed technologies to industry, including a motor-diagnostic tool and an IoT-enabled rural water-monitoring system, moving them from public laboratories toward commercial production. CSIR, established in 1942 and among the world's largest publicly funded research organisations, runs a network of national laboratories across fields from chemistry and metallurgy to biology and instrumentation. Its research output has long faced the perennial challenge of commercialisation — the gap between an invention proven in the lab and a product manufactured and sold at scale, often called the 'valley of death' in innovation. A technology transfer, in which the research body licenses or hands its technology to a firm that will manufacture it, is the bridge across that gap. The transfer illustrates a policy priority of translating public research investment into domestic manufacturing and self-reliance, the value of which lies less in any single device than in the model of publicly funded science reaching the market.
What this tests
Sample questions — answers revealed after test
Q1. In the innovation process, 'technology transfer' most accurately refers to which of the following?
Q2. It is argued that the weakest link in India's innovation chain is commercialisation, not invention. Which one of the following best supports this claim?
Q3. Consider the following statements: 1. The Council of Scientific and Industrial Research (CSIR) functions under the Ministry of Science and Technology and runs a network of national laboratories. 2. Public laboratories can develop technologies whose social value exceeds their immediate commercial return, which private markets might under-provide. 3. Because a technology has been proven in the laboratory, its commercial scale-up is straightforward and requires no further funding or capability. Which of the statements given above are correct?